Pfizer, Astellas Prostate Cancer Drug Promising in Late-Stage Trial September 14, 2017 Pfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages.Read more.Source: Reuters Prostate Cancer News
Pfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages.Read more.Source: Reuters
